does blue cross cover glp 1 drugs Blue Shield of Mass. sees gains after years of GLP-1-related losses The GLP-1 Access Gap: Mapping
Description
6,7 Long-term trials evaluating the effects on the immune system may be warranted owing to increased reports of nasopharyngitis, urinary tract infection, and small elevations in white blood cell count
The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones
According to the World Health Organization, an estimated one billion people worldwide are living with obesity, while rates of type 2 diabetes continue to rise across both developed and emerging economies
10.1001/jamainternmed.2013.2720 [DOI] [PubMed] [Google Scholar] 221.Knapen LM, van Dalem J, Keulemans YC, van Erp NP, Bazelier MT, De Bruin ML, et al
Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-m)
Glenmark Pharmaceuticals Ltd
